These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5668143)

  • 1. Leukopenia induction capacity of 6-mercaptopurine platinum complex in the chick.
    Lewis RW; Rubin BA; Davis JE; Woods JJ
    Proc Soc Exp Biol Med; 1968 Jul; 128(3):857-62. PubMed ID: 5668143
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukopenia-induction capacity of 6-MP palladium complex in the chick.
    Lewis RW; Mack RW; Dennis MJ; Woods JJ
    Proc Soc Exp Biol Med; 1969 Sep; 131(4):1219-22. PubMed ID: 5811978
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukopenia-induction capacity of 6-MP metallo-purine complexes in the rat.
    Lewis RW; Garcia de Quevedo M; Feldman RG
    Res Commun Chem Pathol Pharmacol; 1979 Nov; 26(2):429-32. PubMed ID: 523779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EFFECT OF 6-MERCAPTOPURINE RIBOSIDE (NSC-4911) IN 41 ADULT PATIENTS WITH ACUTE LEUKEMIA.
    WHITTINGTON RM; RIVERS SL; PATNO ME
    Cancer Chemother Rep; 1964 Jan; 34():47-50. PubMed ID: 14116218
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-dose 6-mercaptopurine in inflammatory bowel disease is associated with minimal hematologic toxicity.
    Bernstein CN; Artinian L; Anton PA; Shanahan F
    Dig Dis Sci; 1994 Aug; 39(8):1638-41. PubMed ID: 8050312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease.
    Colonna T; Korelitz BI
    Am J Gastroenterol; 1994 Mar; 89(3):362-6. PubMed ID: 8122645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged remission of severe Crohn's disease after fever and leukopenia caused by 6-mercaptopurine.
    Lobel EZ; Korelitz BI; Vakher K; Panagopoulos G
    Dig Dis Sci; 2004 Feb; 49(2):336-8. PubMed ID: 15104380
    [No Abstract]   [Full Text] [Related]  

  • 8. Is toxicity really necessary? II. Source and analysis of data.
    Bross ID; Rimm AA; Slack NH; Ausman RK; Jones R
    Cancer; 1966 Dec; 19(12):1785-95. PubMed ID: 5927938
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonhuman primates in evaluation of hematotoxicity.
    Saslaw S; Carlisle HN
    Ann N Y Acad Sci; 1969 Jul; 162(1):646-58. PubMed ID: 4979575
    [No Abstract]   [Full Text] [Related]  

  • 10. Indicators of clinical response to treatment with six-mercaptopurine or azathioprine in patients with inflammatory bowel disease.
    Achkar JP; Stevens T; Easley K; Brzezinski A; Seidner D; Lashner B
    Inflamm Bowel Dis; 2004 Jul; 10(4):339-45. PubMed ID: 15475740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of atabrine on x-irradiation-induced leucopenia in chick, rat and mouse.
    KELLEY B; SIMMONS MR; DAY PL; MESCHAN I; DOUGLASS CD
    Proc Soc Exp Biol Med; 1954 Mar; 85(3):460-2. PubMed ID: 13167105
    [No Abstract]   [Full Text] [Related]  

  • 12. 6-Mercaptopurine-related leucopenia and in vivo xanthine oxidase activity.
    Goadsby PJ; Day RO; Kwan YL; Miners J; Birkett DJ
    Lancet; 1986 Oct; 2(8511):869-70. PubMed ID: 2876319
    [No Abstract]   [Full Text] [Related]  

  • 13. THE EFFECT OF CHLORPROTHIXENE AND 6-MERCAPTOPURINE ON THE LA VUFB MOUSE LEUKAEMIA.
    PUJMAN V; CERNOCHOVA S; HAMPEJSOVA H; JEDLICKOVA M
    Neoplasma; 1963; 10():365-70. PubMed ID: 14089957
    [No Abstract]   [Full Text] [Related]  

  • 14. 6-mercaptopurine metabolite levels in children with inflammatory bowel disease.
    Gupta P; Gokhale R; Kirschner BS
    J Pediatr Gastroenterol Nutr; 2001 Oct; 33(4):450-4. PubMed ID: 11698762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced viral infection in the mouse treated with 6-mercaptopurine.
    St Geme JW; Brumbaugh JL; Pajari KL; Singer AD; Toyama PS
    J Lab Clin Med; 1970 Aug; 76(2):213-20. PubMed ID: 5434002
    [No Abstract]   [Full Text] [Related]  

  • 16. Significance of WBC differential when leukopenia is induced by 6-MP for IBD.
    Korelitz BI; Zlatanic J; Smith MJ; Lipe RJ; Baiocco PJ; Gleim GW
    Gastroenterology; 1997 Nov; 113(5):1810-1. PubMed ID: 9352894
    [No Abstract]   [Full Text] [Related]  

  • 17. Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease.
    Wong DR; Coenen MJ; Vermeulen SH; Derijks LJ; van Marrewijk CJ; Klungel OH; Scheffer H; Franke B; Guchelaar HJ; de Jong DJ; Engels LG; Verbeek AL; Hooymans PM;
    J Crohns Colitis; 2017 Feb; 11(2):175-184. PubMed ID: 27402913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of neoplasms in patients who develop sustained leukopenia during or after treatment with 6-mercaptopurine for inflammatory bowel disease.
    Disanti W; Rajapakse RO; Korelitz BI; Panagopoulos G; Bratcher J
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1025-9. PubMed ID: 16765651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pancytopenia associated with thioguanine use].
    van der Burg M; Gerding MN
    Ned Tijdschr Geneeskd; 2018 Oct; 162():. PubMed ID: 30379500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target organ toxicity and leukopenia in Fischer 344 rats given intravenous doses of vinblastine and desacetyl vinblastine.
    Zimmermann JL; Todd GC; Tamura RN
    Fundam Appl Toxicol; 1991 Oct; 17(3):482-93. PubMed ID: 1794652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.